In line with the results of syngeneic tumor models, higher cytotoxic T lymphocytes (CTLs) infiltration predicted better prognosis only when PRMT1 expression level was low in human cancer patients, including COAD, AML, lymphoma, and glioma (Supplementary Fig. 6f–j). This evidence concerns the gene PRMT1 and acute myeloid leukemia.